Ethan Shen PhD - 18 Mar 2026 Form 3 Insider Report for YD Bio Ltd (YDES)

Reporting relationship: CEO, Director
Issuer ticker: YDES
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 10:50:59 UTC
Next SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Ethan Shen

Key filing fact

Ethan Shen PhD filed Form 3 for YD Bio Ltd (YDES) on 18 Mar 2026.

Key facts

This page summarizes Ethan Shen PhD's Form 3 filing for YD Bio Ltd (YDES).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 10:50.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002099921 Primary reporting owner

Shen Ethan PhD

Relationship: CEO, Director
Address: C/O YD BIO LIMITED, 12F., NO. 3, XINGNAN ST., NANGANG DIST., TAIPEI CITY, TAIWAN
Signature: /s/ Ethan Shen
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YDES holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,224,153
Date: 18 Mar 2026
Ownership: Direct

YDES holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 43,120,858
Date: 18 Mar 2026
Ownership: See Footnotes
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported shares are held by YD Biopharma Holding Limited, which is wholly owned by E820N Assets Ltd. (BVI), which is wholly owned by The E820N Trust (the "Trust"). Dr. Shen is the settlor, protector and sole beneficiary of the Trust, and is the beneficial owner of such shares.

SEC remarks

Exhibit 24 - Power of Attorney